Lazard Capital Initiates Coverage on McKesson (MCK) with a Buy
More News related to MCK
- Manson Creek Secures 100% Ownership of Meridian Gold Project
- Manson Creek Confirms Mineralization on Virgin Arm Gold Project
- UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
- Trading Outlook for Imaging3 Inc. Issued by StockPreacher.com
- Manson Creek Resources Negotiates Acquisition of Virgin Arm Gold Project
More News related to New Coverage
- Piper Jaffray Initiates Coverage on Hain Celestial Group (HAIN) with a Neutral; Upside Potential is Limited
- Piper Jaffray Initiates Coverage on Green Mountain Coffee (GMCR) with an Overweight; Several Potential Catalysts
- Piper Jaffray Initiates Coverage on B&G Foods (BGS) with a Neutral; Stock Reflects Fair Valuation
- Piper Jaffray Initiates Coverage on Del Monte Foods (DLM) with a Neutral
- Longbow Starts KR, WFMI at Buy, SWY, SVU at Neutral
Lazard Capital initiates coverage on McKesson (NYSE: MCK) with a Buy. Price target $55.
To see more analyst ratings on MCK Click Here.
McKesson Corporation (McKesson) provides supply, information and care management products and services across the healthcare industry.
Related Categories
New CoverageStocks Mentioned
-0.99Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
